Since New England Biolabs’ inception, parasitology research has been a part of its mission. Inspired to ameliorate the suffering inflicted by parasitic infectious diseases in the developing world, which accounts for approximately 25% of the world’s population, NEB scientists perform research aimed at the development of new anti-parasitic drugs, diagnostics, and vaccines. Further, the group investigates parasite symbionts, genomics, and glycobiology, in hopes of better understanding and exploiting the organisms’ weaknesses.